Carrie D'Andrea's most recent trade in Grace Therapeutics Inc. was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Grace Therapeutics Inc. | Carrie D'Andrea | VP Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Grace Therapeutics Inc. | Carrie D'Andrea | VP Program Management | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 19,740 | 19,740 | - | - | Stock Options (Right to Buy) | |
| Grace Therapeutics Inc. | Carrie D'Andrea | VP Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 19,740 | 19,740 | - | - | Stock Options (Right to Buy) | |
| Grace Therapeutics Inc. | Carrie D'Andrea | VP Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 42,000 | 42,000 | - | - | Stock Options (Right to Buy) |